Close Menu

NEW YORK (GenomeWeb) – Phenomix Sciences — an early-stage spinout of the Mayo Clinic focused on personalized treatments for chronic diseases — announced today that it is launching a $1 million seed financing round through a crowdfunding platform.

The privately held firm said it intends to use the financing to commercialize a new clinical test for obesity. The diagnostic uses technology developed by the Mayo Clinic to analyze metabolomic and DNA biomarkers to characterize obesity and guide more effective weight loss treatments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.